SIGN UP
LOG IN
C
02197
Clover Biopharmaceuticals
0.21
0.00+1.46%Closed15:57 04/25 HKT
OPEN/PREV CLOSE0.200/0.206
TODAY RANGE0.200-0.219
VOL442.50K
MARKET CAP271.09M
52 WEEK RANGE0.185-0.580
AVG VOL (3M)1.94M
% TURNOVER0.03%
TURNOVER92.98K
P/E (TTM)-0.278
% RANGE9.22%
EPS(TTM)-0.752
P/E(FORWARD)0.189
P/B-0.153
BVPS-1.362
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP271.09M
SHARES OUTSTANDING1.30B
NEXT EARNINGS--
FREE FLOAT1.30B
LOT SIZE500
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Reuters·03/31 14:44
CLOVER BIOPHARMACEUTICALS FY NET INCOME RMB -903.4 MILLION
Reuters·08/27/2024 22:07
CLOVER BIOPHARMACEUTICALS H1 NET INCOME RMB -95.1 MILLION
Reuters·06/18/2024 09:38
CLOVER BIOPHARMACEUTICALS LTD: FULL PHASE Ⅰ DATA READOUT IS PLANNED BY YEAR-END 2024
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.